Literature DB >> 12241805

Clinical haemochromatosis in HFE mutation carriers.

K J Allen, B Warner, M B Delatycki.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12241805     DOI: 10.1016/s0140-6736(02)09583-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  The Southern French registry of genetic hemochromatosis: a tool for determining clinical prevalence of the disorder and genotype penetrance.

Authors:  Patricia Aguilar-Martinez; Michael Bismuth; François Blanc; Pierre Blanc; Severine Cunat; Olivier Dereure; Pierre Dujols; Muriel Giansily-Blaizot; Christian Jorgensen; Amadou Konate; Dominique Larrey; Alain Le Quellec; Thibault Mura; Isabelle Raingeard; Jeanne Ramos; Eric Renard; Florence Rousseau; Jean-François Schved; Marie-Christine Picot
Journal:  Haematologica       Date:  2010-02-09       Impact factor: 9.941

2.  Reverse cascade screening of newborns for hereditary haemochromatosis: a model for other late onset diseases?

Authors:  E Cadet; D Capron; M Gallet; M-L Omanga-Léké; H Boutignon; C Julier; K J H Robson; J Rochette
Journal:  J Med Genet       Date:  2005-05       Impact factor: 6.318

3.  HFE Cys282Tyr homozygotes with serum ferritin concentrations below 1000 microg/L are at low risk of hemochromatosis.

Authors:  Katrina J Allen; Nadine A Bertalli; Nicholas J Osborne; Clare C Constantine; Martin B Delatycki; Amy E Nisselle; Amanda J Nicoll; Dorota M Gertig; Christine E McLaren; Graham G Giles; John L Hopper; Gregory J Anderson; John K Olynyk; Lawrie W Powell; Lyle C Gurrin
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

4.  ironXS: high-school screening for hereditary haemochromatosis is acceptable and feasible.

Authors:  Martin B Delatycki; Michelle Wolthuizen; Veronica Collins; Elizabeth Varley; Joanna Craven; Katrina J Allen; Lyle C Gurrin; Maryanne Aitken; M Kaye Trembath; Lyndal Bond; Gabrielle R Wilson; Sarah E M Stephenson; Ivan Macciocca; Chriselle Hickerton; Paul J Lockhart; Sylvia A Metcalfe
Journal:  Eur J Hum Genet       Date:  2012-01-11       Impact factor: 4.246

Review 5.  Recent advances in understanding haemochromatosis: a transition state.

Authors:  K J H Robson; A T Merryweather-Clarke; E Cadet; V Viprakasit; M G Zaahl; J J Pointon; D J Weatherall; J Rochette
Journal:  J Med Genet       Date:  2004-10       Impact factor: 6.318

Review 6.  Iron storage disease: facts, fiction and progress.

Authors:  Ernest Beutler
Journal:  Blood Cells Mol Dis       Date:  2007-05-31       Impact factor: 3.039

7.  Quality of life utility values for hereditary haemochromatosis in Australia.

Authors:  Barbara de Graaff; Amanda Neil; Kristy Sanderson; Kwang Chien Yee; Andrew J Palmer
Journal:  Health Qual Life Outcomes       Date:  2016-02-29       Impact factor: 3.186

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.